Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults
Ontology highlight
ABSTRACT: This study evaluates the efficacy, safety and tolerability of NER1006 versus Trisulfate Solution (TS) in adult patients requiring bowel cleansing prior to any procedure that requires a clean bowel, using a 2-Day evening/morning Split-Dosing regimen. Approximately 540 patients will be randomised with the aim of achieving a minimum of 245 patients in each of the 2 groups.
DISEASE(S): Colorectal Carcinoma,Colon Cancer,Colon Cleansing,Colorectal Neoplasms
PROVIDER: 2175490 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA